[Sensory neuronopathy].
The authors present the question of sensory neuronopathy which are disorders affecting intervertebral ganglia. The neuropathological background and clinical symptoms of sensory neuronopathy are emphasised, as well as diagnostic difficulties resulting from a variety of ethiological conditions: toxic, inflammatory, and autoimmunological ones, and from lack of unequivocal clinical criteria enabling a difference diagnosis along with neuropathy and radiculopathy, which in turn requires a broad spectrum of diagnostic tests and prolonged observation of patients. The authors discuss also the clinical outcome, prognosis, and current therapeutic possibilities focusing on intensive immunosuppressive management.
Jankowicz
E
E
Kliniki Chorób Nerwowych AM w Białymstoku.
Drozdowski
W
W
D000888:Antibodies, Anti-Idiotypic / Q000097:blood / Q000134:cerebrospinal fluid; D003937:Diagnosis, Differential; D017952:Ganglia, Invertebrate / Q000473:pathology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D009474:Neurons / Q000473:pathology*; D012678:Sensation Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D014057:Tomography, X-Ray Computed
D000888:Antibodies, Anti-Idiotypic; D007166:Immunosuppressive Agents